Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -2.544% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) COc1cccc2sc(Nc3nnc(-c4ccc(F)cc4)o3)nc12
(b) CCN(Cc1ccccc1)C(=O)C1CCN(Cc2ccc(OC)c(OC)c2OC)CC1.O=C(O)C(=O)O
(c) O=C(CCN1CCCC1=O)NC1CCCc2c1cnn2-c1ccc(F)cc1F
Answer: c. O=C(CCN1CCCC1=O)NC1CCCc2c1cnn2-c1ccc(F)cc1F
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCN1CCCC1=O)NC1CCCc2c1cnn2-c1ccc(F)cc1F
O=C(CCN1CCCC1=O)NC1CCCc2c1cnn2-c1ccc(F)cc1F
N-[1-(2,4-difluorophenyl)-4,5,6,7-tetrahydroindazol-4-yl]-3-(2-oxopyrrolidin-1-yl)propanamide